Loading market dashboard
AIM ImmunoTech Inc.
AIMHealthcareAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and Ampligen's previously published antiviral research
By Andrew Rice, Partner and Portfolio Manager We may often come off as skeptical about AI in our newsletter. Our skepticism is primarily centered on the AI capital spend and AI company valuations rather than the AI tools themselves, which we have found both useful and exciting.
Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Treatment, More Than One Month Ahead of Original Target Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Treatment, More Than One Month Ahead of Original Target
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following lethal doses of Ebola
Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF) announced plans to raise approximately £5.5 million through a placing as the medical device company moves to strengthen its balance sheet while pursuing the sale of its remaining stake in Creo Medical Europe. The AIM-listed group said it intends to issue around 36.7 million new shares at 15p each, a 31.9% premium to Thursday's closing mid-market price of 11.4p.
OCALA, Fla. , May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company", today announced that it has entered into definitive agreements for a registered direct offering priced at-the-market under NYSE Rules of an aggregate of 7,519,351 shares of common stock, par value $0.
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at-the-market under NYSE Rules of an aggregate of 7,519,351 shares of common stock, par value $0.001 per share (the “Common Stock”) (or common stock equivalents in lieu thereof) at a purchase price of $0.325 per share. The gross proceeds to the Company from the offering are expected to be approximately $2.4 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company will issue and sell unregistered Series I warrants (the “Series I Warrants”) to purchase up to 15,038,702 shares of Common Stock. The Series I Warrants will have an exercise price of $0.325 per share, will be exercisable subject to stockholder approval and will expire five (5) years from the initial exercise date.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has told investors that its planned Augusta-1 exploration well at South Prudhoe on Alaska's North Slope remains on track for a first-quarter 2027 spud, as the company advances permitting, logistics and farm-out discussions. The AIM and ASX-listed explorer said Augusta-1 is designed to test up to 133.7 million barrels of gross unrisked 2U prospective resources, or 111.4 million barrels net to 88 Energy, across stacked Ivishak, Kuparuk and Brookian reservoir targets.
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- #isaca--CMMI Institute, a global leader in helping organizations reduce risk, boost performance, and build capability, is now extending this guidance to artificial intelligence, and has recently completed a pilot program for its new AI Maturity (AIM) framework. AIM enables organizations to assess, benchmark and improve how AI is implemented across real-world enterprise and regulatory environments, linking AI practices and governance to measurable, scalable outcomes. T.
Increase in stockholder equity and note extension strengthen Company's ability to advance pancreatic cancer development strategy Increase in stockholder equity and note extension strengthen Company's ability to advance pancreatic cancer development strategy
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) shares fell 8.3% to 1.33p after North Yorkshire Council refused planning permission for the Cloughton gas appraisal well in North Yorkshire. The AIM-listed oil and gas group said the decision went against the recommendation of the council's own planning officers, who had advised the local planning authority to approve the application following reviews by 13 independent experts.
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has conditionally raised US$11.5 million to back a busy exploration programme, including drilling on the Chevron-operated Nabba-1 well in Namibia's PEL 90. The fundraise was priced at 22.5p per new common share on AIM and C$0.41 on the TSX-V, with the company set to issue 38.0 million new shares.
CelLBxHealth PLC (AIM:CLBX, FRA:DWV), the AIM-listed circulating tumour cell (CTC) diagnostics company, has secured a collaboration with AdventHealth, one of the largest faith-based health systems in the United States, to deploy its Parsortix platform in two clinical cancer studies. The trials, titled ACTION and SUNRISE, will use CelLBxHealth's technology to isolate and analyse CTCs from blood samples taken from patients undergoing treatment for colon, gastrointestinal and lung cancers.
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) told investors that its Crossroads well in Garvin County, Oklahoma, has been drilled on budget to a target depth of 4,600 feet, with evaluation and testing scheduled to begin in mid-June. The AIM-listed onshore hydrocarbons company, which has a 43% interest in the well, said electric logs have been acquired and several zones of interest and test intervals identified.
Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial Segment featuring Professor Doctor Casper H.J. van Eijck, Professor and Pancreato-biliary Surgeon at Erasmus MC and an oncology consultant for AIM ImmunoTech, is now available on demand here OCALA, Fla.
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF), the AIM-listed life sciences company developing gut microbiome products and healthy sugar substitutes, saw its shares jump 13.5% to 5.68p after announcing plans to demonstrate its SweetBiotix products to shareholders at a London event in June. The company reported a breakthrough in the manufacture of SweetBiotix in November 2025, achieving higher yields of a purer, more concentrated and better-tasting product with lower ingredient and production costs.
Aimia Inc. (AIM:CA) Shareholder/Analyst Call Transcript
ALPHARETTA, Ga., May 13, 2026 (GLOBE NEWSWIRE) -- Candor Technology, Inc., a leader in AI-driven mortgage decisioning, is now integrated with Freddie Mac's AIM Check API, enabling automated income calculation for W-2 borrowers directly through Candor's patented Loan Engineering System (LES).
Aimia Inc. (AIM:CA) Q1 2026 Earnings Call Transcript
Cavendish sees more than fivefold upside in Jersey Oil and Gas PLC (AIM:JOG, OTC:JYOGF), arguing that the AIM-listed North Sea developer remains well placed to unlock value from its Greater Buchan Area interests. The stockbroker, in a note, repeated a ‘Buy' recommendation and a 537p target price, implying a 407% premium to the current 106p share price.
Cavendish sees huge upside (more than thirteenfold) for 88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), with the bullish house-broker highlighting that the explorer has reshaped its Namibia farm-in agreement, stripping out US$15 million of anticipated funding exposure while retaining a 20% stake in frontier acreage. The broker reiterated its Buy rating and 19.8p target price on the AIM-listed company, implying 1,366% upside from a 1.4p share price.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) announced it has secured its 20% working interest in Namibia's PEL 93 on an unconditional basis while cutting about US$15 million of minimum future funding exposure under an amended farm-in agreement. The AIM- and ASX-listed explorer said the revised deal with operator Monitor Exploration cancels Stage 2 and Stage 3 farm-in obligations, removes reassignment risk and simplifies the original commercial structure.
OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the Company and certain accredited investors to exercise certain outstanding Class A, Class B, Class C, Class D, Class E and Class F Warrants (the “Existing Warrants”) to purchase up to an aggregate of 8,719,928 shares of common stock at a reduced exercise price of $0.48 per share for gross proceeds of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
Final UPMC Primary Endpoint Report Details Positive Data from Ovarian Cancer Clinical Trial Combining Ampligen, Pembrolizumab and Cisplatin Final UPMC Primary Endpoint Report Details Positive Data from Ovarian Cancer Clinical Trial Combining Ampligen, Pembrolizumab and Cisplatin
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) told investors that its digital infrastructure push in the UAE has moved a step forward after its subsidiary signed an agreement aimed at supporting licensing, power access and site development for crypto mining operations. The AIM-listed company said Active Mining Group has entered into a services and facilitation agreement with the Private Office of HH Sheikh Mohammed bin Ahmed bin Hamdan bin Mohammed Al Nahyan, with Black Road Investment Group and affiliated companies acting as liaison partner.
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) said drilling has started at the Crossroads Well in Oklahoma, putting the AIM-quoted explorer on a short timeline to the next operational readout from its US portfolio. The small-cap oil and gas company said it had been informed by operator Reach Oil and Gas that the well was spudded on 5 May 2026.
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) said the rig for the Crossroads Well in Southern Oklahoma remains under maintenance and repair, pushing the next drilling timetable marker into early May. The AIM-listed onshore hydrocarbon company said operator Reach Oil and Gas Company Inc had informed it that a spud date would be provided in early May.
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) opened Monday's session on the back foot, before rallying, in the wake of the latest UK planning dispute for onshore oil and gas. The AIM-listed oil and gas explorer, in a statement, said plans to appeal after North Yorkshire Council's planning committee indicated it was minded not to approve the company's proposed well at Burniston on the Cloughton prospect.
Oscillate PLC (LSE:SRVL), the AIM-bound shell company rebranding as Serval Resources, has completed the acquisition of Kalahari Copper and begun trading on London's junior market, raising nearly £3 million to fund exploration across two emerging African copper belts. The company's shares began trading on AIM at 8 am today under the ticker SRVL, having previously been listed on the Access segment of the AQSE Growth Market.
The AIM-listed virtual product placement company says it may have to enter administration or liquidation in the near term after failing to secure fresh capital Mirriad Advertising PLC (AIM:MIRI, FRA:8WQ, OTCQX:MMDDF), the virtual in-content advertising technology company, has warned it may be forced into administration or liquidation after efforts to secure emergency funding failed, sending shares down as much as 50% in early trading. The company said trading conditions deteriorated sharply following the escalation of geopolitical tensions in the Middle East, particularly conflict involving Iran, which hit its key regional market during what should have been its busiest seasonal period.
CelLBxHealth PLC (AIM:CLBX, FRA:DWV) shares rose 8% to 0.99p after the AIM-listed circulating tumour cell specialist announced a research collaboration with The Royal Marsden NHS Foundation Trust to study a novel blood-based testing approach in advanced lung cancer patients. The two organisations will jointly conduct a clinical study in 200 patients with advanced non-small cell lung cancer (NSCLC), the most common form of the disease.
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) shares were up 11% on Monday, to 0.11p, after the firm told investors that its Ghummud site in the UAE has been fully energised ahead of schedule, potentially pulling forward revenue as the company pushes to build out a digital infrastructure platform around acquired grid connections. The AIM-listed group said modular digital infrastructure deployment is already underway at the site and that operations are now expected to begin materially sooner than the previously indicated 10-12 week timeline.
HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has been selected by Renaissance Philanthropy's Chimaera Fund to join a US Air Force-backed demonstration programme, giving the AIM-listed gas explorer a foothold in a project tied to military energy resilience and highlighting a possible second strategic use for its Montana geology. The group was chosen from nearly 30 respondents to a request for information aimed at finding partners with relevant well infrastructure, hydrogen-related subsurface data and active exploration programmes near key Air Force bases.
(NYSE AMERICAN:CMCL)(AIM:CMCL)(VFEX:CMCL) SAINT HELIER, JE / ACCESS Newswire / April 17, 2026 / Caledonia Mining Corporation Plc (the "Company") announces that further to the announcement released on March 23, 2026 of a quarterly dividend of 14 United States cents (US$0.14) per share to be paid on April 17, 2026, the payment date for holders of depositary interests representing shares trading on AIM will now be April 20, 2026. All other details relating to the dividend, as set out in the announcement of March 23, 2026, remain unchanged.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from the UK Medicines and Healthcare products Regulatory Agency for its TOPICAL trial, with interim data expected this summer. The trial is investigating POLB 001, which is being developed as a potential first-approved preventative therapy for cytokine release syndrome (CRS), a serious immune reaction triggered by cancer immunotherapies, including CAR T-cell therapies and bispecific antibodies.
OCALA, Fla., April 13, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today advised that its audited consolidated financial statements for the fiscal year ended December 31, 2025, contained an audit report from its independent registered public accounting firm with a going concern emphasis of matter. Release of this information is required by Section 610(b) of the NYSE American Company Guide, and does not represent any change or amendment to any of the Company's filings for the fiscal year ended December 31, 2025.
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z) told investors it has so far found no evidence of unauthorised access to its systems or data, after investigating an alleged cyber threat flagged to the company around 10 days ago. The AIM-listed transport safety technology group said a third party had named it online alongside claims that some company data had been accessed.
Impax Asset Management (AIM:IPX, FRA:LW4) shares dropped in Friday morning's deals, losing 21% to 98.68p, as the firm reported assets under management fell 8% over its fiscal second quarter to £22.3 billion, as continued client redemptions prompted the AIM-listed specialist investor to guide for lower full-year revenue. Net outflows totalled £2.01 billion in the three months to 31 March 2026, driven principally by listed equities, while performance, market movements and foreign exchange added just £83 million.
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) has announced that the Crossroads well in southern Oklahoma is set to be spudded on or around 16 April, giving investors a near-term drilling catalyst on a project where the company already has its funding in place. The AIM-listed group holds a 43% interest in Crossroads, with Reach Oil and Gas acting as operator, and, Union Jack said its share of drilling costs has already been funded, de-risking the immediate cash call ahead of operations.
Cavendish sees very substantial upside for 88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) after the AIM-listed explorer secured access to a 3D seismic dataset over its Kad River East acreage in Alaska, with the broker reiterating a Buy rating and 19.8p target price (compared to the current price of 1.5p per share). The stockbroker, in a note, highlighted that the firm's newly licensed Kad River 3D survey covers the entirety of the recently acquired leases and strengthens the case for an active, multi-reservoir petroleum system already indicated by legacy 2D seismic and historic well data.
Sorted Group Holdings PLC (AIM:SORT) saw its share price halve to 10p after it unveiled plans to dispose of its main operating business for £1 and become an AIM cash shell, just two years after its arrival via reverse takeover. The AIM-listed software group said it intends to sell Sorted Group Ltd for a nominal consideration, subject to shareholder approval later this month.
The AIM-listed rare earths company upsized its placing after strong demand, though shares fell back on dilution concerns. Shares in Mkango Resources Ltd (AIM:MKA, TSX-V:MKA, OTC:MKNGF), the rare earths developer, fell 13% to 33.6p on Wednesday despite the company completing a fundraise that was significantly oversubscribed and upsized from its original £10 million target to £12.5 million.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF)shares rose as much as 10% in Tuesday morning trading after the AIM-listed biopharmaceutical company secured its first national patent grant for POLB 001. This is the drug developer's lead candidate for preventing a serious side effect of cancer immunotherapy.
ExxonMobil, ConocoPhillips, Repsol and Shell have just competed at the most successful lease sale ever held in Alaska's National Petroleum Reserve. The timing could hardly be better for 88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), the AIM-listed explorer advancing plans to drill one of the North Slope's most promising untested prospects.
Shares in Spectra Systems Corporation (AIM:SPSY, OTC:SCTQ) rose 8% to 136p after the AIM-listed banknote authentication and security technology company reported a doubling of adjusted earnings per share following the first deliveries under a major sensor contract. Revenue rose 30.7% to $64.3 million for the year ended 31 December 2025, while adjusted EBITDA (earnings before interest, tax, depreciation and amortisation, adjusted for non-cash items) surged 82.9% to $27.3 million and adjusted profit before tax and amortisation more than doubled to $25.2 million.
Directa Plus PLC (AIM:DCTA, OTC:DTPKF) shares fell 17.5% to 7.01p after the graphene products company warned it could be placed into administration if it fails to secure fresh funding within weeks. The AIM-listed group said it was in advanced discussions with an unnamed institutional investor for a funding facility of up to £2.5 million to extend its cash runway, but cautioned there was "no certainty any funding transaction will be concluded".
Shares in Greatland Resources Ltd (AIM:GGP, OTC:GRLGF, FRA:G8G, ASX:GGP) rose 7% to 545.45p after the AIM-listed gold and copper miner reported a 150% expansion in the mineral resource at its flagship Telfer operation in Western Australia, taking the total to 8 million ounces of gold. The updated December 2025 estimate adds 4.8 million ounces at a discovery cost of approximately $5 per ounce, with the higher-confidence measured and indicated category growing 163% to 3.8 million ounces, providing a stronger foundation for mine planning and conversion into mineable reserves.
Shares in Mirriad Advertising PLC (AIM:MIRI, FRA:8WQ, OTCQX:MMDDF) fell 47% to 0.0029p after the AIM-listed virtual product placement company warned it will need to raise further funds before publishing its annual results, with cash standing at approximately £675,000 as of 27 March 2026. Virtual product placement is a technology that digitally inserts branded products into video content after filming, allowing advertisers to reach audiences without traditional ad breaks.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), the AIM and ASX-listed oil and gas explorer, has commenced permitting and planning for the Augusta-1 exploration well on Alaska's North Slope, targeting prospective resources of 64 million barrels of oil equivalent on a best-estimate, gross unrisked basis. The well is designed to test the stacked Ivishak and Kuparuk reservoirs within the North-West Lease Area of the company's South Prudhoe project, a 52,269-acre position situated immediately south of the prolific Prudhoe Bay and Kuparuk River producing units, in which 88 Energy holds a 100% working interest.
Hargreaves Services Plc (AIM:HSP, OTC:HGRVF) the AIM-listed environmental services group, saw its shares jump 8% after it launched a tender offer to return up to £20 million to shareholders at 850 pence per share, a premium of 16% to Thursday's closing price of 730 pence. The offer has been increased from the £15 million figure flagged in the company's interim results in January, when the 850 pence price also represents a premium of 26.9% to the 670 pence closing price on the day before that announcement.
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z), the AIM-listed AI-powered operator monitoring systems company, expects adjusted EBITDA to turn positive in both the third quarter and second half of its current financial year as approaching European road safety regulation drives a significant increase in automotive royalty volumes. The company said royalties from automotive production volumes are projected to rise significantly in the coming quarters as the General Safety Regulation (GSR), which mandates driver monitoring technology in new European vehicles, moves into active implementation and OEMs transition their compliance strategies into production.
TORONTO, ON / ACCESS Newswire / March 26, 2026 / Sintana Energy Inc. (TSX-V:SEI)(AIM:SEI)(OTCQX:SEUSF) ("Sintana" or the "Company") announces that its board of directors (the "Board") has approved amendments to the Company's By-Law No. 1 (the "By-law Amendments") in order to, amongst other things, comply with the AIM Rules for Companies (as published by the London Stock Exchange plc, as amended from time to time) (the "AIM Rules") following the Company's admission to trading on the AIM Market of the London Stock Exchange ("AIM") on December 23, 2025.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) aims to raise up to the equivalent of £2.62 million (A$5.03 million) to help fund drill plans in Alaska. The AIM and ASX-listed explorer pricing the issue at A$0.029 a share, or about 1.508p.
Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.
80 Mile PLC (AIM:80M, OTCQB:BLLYF) shares jumped on Wednesday as it revealed it is moving its shares from the London Stock Exchange's SETSqx platform to SETS from today, a step the company said should widen investor access and improve liquidity. The AIM-listed explorer and developer said the move to SETS, the exchange's electronic order book for equities, is intended to broaden its shareholder base and make the stock more accessible to investors, including those trading internationally, through traditional order-book dealing.
AIM also intends to pursue Japanese Orphan Drug Designation for Ampligen in treatment of pancreatic cancer AIM also intends to pursue Japanese Orphan Drug Designation for Ampligen in treatment of pancreatic cancer
The Malawi-based miner's flagship deposit remains the world's largest natural rutile reserve Sovereign Metals Ltd (ASX:SVM, OTCQX:SVMLF, AIM:SVML, FRA:SVM), the AIM-listed critical minerals company, has significantly upgraded the resource estimate for its Kasiya project in Malawi, sending shares up 9% to 44p. The updated mineral resource estimate (MRE) shows measured and indicated contained rutile rising 32% to 16.1 million tonnes, covering 1.65 billion tonnes of ore graded at 0.98% rutile.
AIM-quoted Alaska oil explorer 88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) is a potentially mispriced infrastructure play, that's according to analysts at stockbroker Cavendish, who have slapped a 'Buy' rating and 22.5p target price on the small-cap stock. It's a speculative call that implies more than 11-fold upside from 88 Energy's current 1.8p share price.
